triazoles has been researched along with cyclin d1 in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 21 (84.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, RY; He, QJ; Lou, YJ; Yang, B | 1 |
| Murphy, PV; O'Boyle, KM; Zhao, Y; Zhou, Y | 1 |
| Baselga, J; Bellet, M; Bianchi, G; Campone, M; Dixon, JM; Gardner, H; Greil, R; Jonat, W; Kubista, E; Lane, HA; Manikhas, A; Mayordomo, J; Molloy, B; Phillips, P; Rugo, HS; Semiglazov, V; Steinseifer, J; Stumm, M; Tokaji, E; van Dam, P | 1 |
| Alfieri, RR; Belletti, S; Bonelli, MA; Bottini, A; Cavazzoni, A; Dowsett, M; Evans, DB; Fox, SB; Fumarola, C; Galetti, M; Gatti, R; Generali, D; Harris, AL; La Monica, S; Martin, LA; Petronini, PG | 1 |
| Albrecht, JH; Anttila, C; Blomquist, CH; Delvoux, B; Hanse, EA; Mason, JI; Mullany, LK; Romano, A | 1 |
| Beyer, A; Cai, WY; Elledge, R; Fuqua, S; Hilsenbeck, S; Huang, J; Massarweh, S; Rimawi, M; Sexton, K; Tham, YL; Tsimelzon, A; Weiss, H | 1 |
| Alinger, B; Berr, F; Di Fazio, P; Fuereder, J; Kiesslich, T; Neureiter, D; Oberdanner, C; Ocker, M; Pichler, M; Wachter, J | 1 |
| Brown, M; Cuzick, J; Dowsett, M; Howell, A; Landberg, G; Lundgren, K; Pineda, S; Salter, J; Zabaglo, L | 1 |
| Bane, F; Byrne, C; Conroy, RM; Gaora, PÓ; Hao, Y; Hill, AD; McBryan, J; McIlroy, M; O'Hara, J; Tibbitts, P; Vareslija, D; Young, LS | 1 |
| Dreyling, M; Granot, G; Levi, I; Mor-Tzuntz, R; Nathan, I; Shpilberg, O; Vazana-Barad, L | 1 |
| Ford, SJ; Jansson, PJ; Kalinowski, DS; Kovacevic, Z; Lovejoy, DB; Lui, GY; Obeidy, P; Richardson, DR; Sharp, DM; Tselepis, C | 1 |
| Chang, LS; Chen, CY; Chung, MI; Hsiao, CT; Hsu, CC; Hu, WP; Lee, PH; Lin, YT; Lin, YY; Wang, JJ; Yu, WT | 1 |
| Abbas, SE; Abdel-Aziz, HA; Abou-Seri, SM; Eladwy, RA; Fares, M; Youssef, MM | 1 |
| Aberdeen, GW; Albrecht, ED; Dumitrescu, A; Pepe, GJ | 1 |
| Boer, K; Bondarenko, IM; Crown, JP; Ettl, J; Finn, RS; Fowst, C; Huang, X; Kim, ST; Kulyk, SO; Lang, I; Patel, R; Pinter, T; Randolph, S; Schmidt, M; Shparyk, Y; Slamon, DJ; Thummala, AR; Voytko, NL | 1 |
| Chinthakindi, PK; Hamid, A; Hussain, A; Khan, I; Koul, S; Majeed, R; Sangwan, PL; Saxena, AK; Sharma, PR | 1 |
| Bansal, N; Bertino, JR; DiPaola, RS; Mishra, PJ; Stein, M | 1 |
| Andreeff, M; Davis, RE; Fujimura, T; Ishizawa, J; Kauffman, M; Kazuno, S; Kojima, K; Ma, W; Matsushita, H; Miida, T; Sekihara, K; Shacham, S; Tabe, Y; Ueno, T; Wang, Z; Yamamoto, S | 1 |
| Ali Alharbi, S; Ananda, H; Baburajeev, CP; Bender, A; Chinnathambi, A; Dhananjaya Mohan, C; Fuchs, JE; Girish, KS; Jagadish, S; Li, F; Rangappa, KS; Rangappa, S; Sethi, G; Sivaraman Siveen, K; Zayed, ME; Zhang, J | 1 |
| Festuccia, C; Gravina, GL; Kauffman, M; Landesman, Y; Mancini, A; Marampon, F; McCauley, D; Sanita, P; Shacham, S; Ventura, L; Vitale, F | 1 |
| Aytaç, PS; Çetin-Atalay, R; Durmaz, I; Houston, DR; Tozkoparan, B | 1 |
| Junyan, P; Shujuan, Y; Shulin, G; Xia, X; Yan, C | 1 |
| Cheng, SY; Enomoto, K; Meltzer, P; Qi, J; Willingham, MC; Zhao, L; Zhu, X; Zhu, YJ | 1 |
| Bai, JY; She, C; Xiang, T; Yu, DJ; Zhao, TL; Zhou, XZ | 1 |
| Dong, G; Du, G; Hu, Q; Lu, C; Martin, EM; Qin, Y; Wang, X; Xia, Y; Zhang, R | 1 |
4 trial(s) available for triazoles and cyclin d1
| Article | Year |
|---|---|
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Cell Proliferation; Chemotherapy, Adjuvant; Class I Phosphatidylinositol 3-Kinases; Cyclin D1; Double-Blind Method; Europe; Everolimus; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Letrozole; Middle Aged; Mutation; Neoadjuvant Therapy; Nitriles; Palpation; Phosphatidylinositol 3-Kinases; Phosphorylation; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Ribosomal Protein S6 Kinases; Sirolimus; Time Factors; Treatment Outcome; Triazoles; United States | 2009 |
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Cell Cycle; Cyclin D1; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Ki-67 Antigen; Male; Mitogen-Activated Protein Kinases; Neoadjuvant Therapy; Nitriles; Oncogene Protein v-akt; Proto-Oncogene Proteins; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Triazoles | 2011 |
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin D1; Female; Follow-Up Studies; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles | 2012 |
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p16; Disease-Free Survival; Drug Administration Schedule; Europe; Female; Humans; Intention to Treat Analysis; Letrozole; Middle Aged; Molecular Targeted Therapy; Nitriles; North America; Piperazines; Postmenopause; Proportional Hazards Models; Protein Kinase Inhibitors; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Republic of Korea; South Africa; Time Factors; Treatment Outcome; Triazoles | 2015 |
21 other study(ies) available for triazoles and cyclin d1
| Article | Year |
|---|---|
Contragestazol (DL111-IT) inhibits proliferation of human androgen-independent prostate cancer cell line PC3 in vitro and in vivo.
Topics: Androgens; Animals; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Dose-Response Relationship, Drug; Female; G1 Phase; Humans; Immunosuppressive Agents; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Resting Phase, Cell Cycle; Retinoblastoma Protein; Transplantation, Heterologous; Triazoles | 2005 |
Hybrids of 1-deoxynojirimycin and aryl-1,2,3-triazoles and biological studies related to angiogenesis.
Topics: 1-Deoxynojirimycin; Aminopeptidases; Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Cattle; Cell Cycle; Cell Line; Cell Movement; Cell Proliferation; Cyclin D1; Endothelial Cells; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Metalloendopeptidases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Stress Fibers; Triazoles | 2008 |
Synergistic activity of letrozole and sorafenib on breast cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Inducing Factor; Aromatase; Aromatase Inhibitors; Benzenesulfonates; Breast Neoplasms; Caspase 7; Caspase 9; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cytochromes c; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Female; Humans; Letrozole; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Niacinamide; Nitriles; Phenylurea Compounds; Phosphoproteins; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-myc; Pyridines; Retinoblastoma Protein; Ribosomal Protein S6 Kinases, 70-kDa; Sorafenib; Testosterone; Time Factors; TOR Serine-Threonine Kinases; Transfection; Triazoles | 2010 |
Cyclin D1 regulates hepatic estrogen and androgen metabolism.
Topics: Androgens; Animals; Aromatase Inhibitors; Cell Line, Tumor; Cyclin D1; Estrogens; Gene Expression Profiling; Gene Expression Regulation; Humans; Letrozole; Liver; Liver Regeneration; Male; Mice; Mice, Inbred BALB C; Nitriles; Triazoles | 2010 |
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Clinical Trials as Topic; Cyclin D1; Flavonoids; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Quercetin; RNA, Messenger; Sulfonamides; Triazoles; Vimentin; Wnt Signaling Pathway | 2012 |
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
Topics: Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Letrozole; MAP Kinase Signaling System; Neoplasm Recurrence, Local; Nitriles; Nuclear Receptor Coactivator 3; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Transcription, Genetic; Trefoil Factor-1; Triazoles; Tumor Suppressor Proteins; Up-Regulation | 2012 |
Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin D1; Deferasirox; Gene Expression Regulation, Neoplastic; Humans; Iron; Iron Chelating Agents; Lymphoma, Mantle-Cell; Proteasome Endopeptidase Complex; Proteolysis; RNA, Messenger; Triazoles | 2013 |
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.
Topics: Administration, Oral; Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Copper; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Deferasirox; Female; Humans; Iron; Iron Chelating Agents; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neuroectodermal Tumors, Primitive, Peripheral; Protein Serine-Threonine Kinases; Receptors, Transferrin; Small Cell Lung Carcinoma; Transplantation, Heterologous; Triazoles; Zinc | 2013 |
Synthesis, DNA-binding abilities and anticancer activities of triazole-pyrrolo[2,1-c][1,4]benzodiazepines hybrid scaffolds.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodiazepines; Cell Line, Tumor; Cyclin D1; DNA; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Humans; Isomerism; Mice; Pyrroles; Triazoles; Up-Regulation | 2013 |
Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Pyrimidines; Triazoles | 2014 |
Placental estrogen suppresses cyclin D1 expression in the nonhuman primate fetal adrenal cortex.
Topics: Adrenal Cortex; Animals; Aromatase Inhibitors; Carrier Proteins; Cyclin D1; Cyclin-Dependent Kinases; Dehydroepiandrosterone Sulfate; Estradiol; Estrogens; Female; Fetal Development; Fetal Weight; Hydrocortisone; Ki-67 Antigen; Letrozole; Male; Nitriles; Papio anubis; Placenta; Pregnancy; Triazoles | 2014 |
PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.
Topics: Betulinic Acid; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HL-60 Cells; Humans; MCF-7 Cells; Neoplasms; Pentacyclic Triterpenes; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Signal Transduction; Triazoles; Triterpenes | 2016 |
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
Topics: Adenylate Kinase; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Docetaxel; Drug Resistance, Neoplasm; Enzyme Activation; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; Humans; Male; Metformin; Neoplasm Invasiveness; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Taxoids; Triazoles; Up-Regulation | 2015 |
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
Topics: Acrylates; Active Transport, Cell Nucleus; Antineoplastic Agents; B-Lymphocytes; Cell Line, Tumor; Cyclin D1; DNA-Binding Proteins; Elongation Factor 2 Kinase; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Humans; Karyopherins; Organelle Biogenesis; Peptide Elongation Factor 1; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-pim-1; Receptors, Cytoplasmic and Nuclear; Ribosomes; Signal Transduction; Transcription Factors; Transcription, Genetic; Triazoles; Tumor Suppressor Protein p53 | 2015 |
Development of Novel Triazolo-Thiadiazoles from Heterogeneous "Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors.
Topics: Animals; Antineoplastic Agents; Benzofurans; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Movement; Chromones; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Mice; Models, Molecular; Neoplasm Invasiveness; Neovascularization, Pathologic; Poly(ADP-ribose) Polymerases; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Structure-Activity Relationship; Survivin; Thiadiazoles; Triazoles | 2015 |
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.
Topics: Adult; Analgesics; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Neoplasm Grading; Oxadiazoles; Prostatic Neoplasms; Survivin; Triazoles; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cyclin D1; Cytoskeletal Proteins; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; HCT116 Cells; Hepatocytes; Humans; Inhibitory Concentration 50; MAP Kinase Kinase Kinase 5; MCF-7 Cells; Molecular Docking Simulation; Nuclear Proteins; Oxidative Stress; Protein Structure, Secondary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship; Signal Transduction; Thiadiazines; Triazoles | 2016 |
The Antitumor Effect of DYC-279 on Human Hepatocellular Carcinoma HepG2 Cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; CDC2 Protein Kinase; Cell Proliferation; Cell Survival; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinases; Cytochromes c; Hep G2 Cells; Humans; Liver Neoplasms; Piperazines; Proto-Oncogene Proteins c-bcl-2; Triazoles | 2016 |
Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.
Topics: Animals; Azepines; Cell Line, Tumor; Cell Proliferation; Chromatin Assembly and Disassembly; Cyclin D1; Cyclin-Dependent Kinase 4; E2F3 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Mice; Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Rats; Signal Transduction; Thyroid Hormone Receptors beta; Thyroid Neoplasms; Triazoles; Xenograft Model Antitumor Assays | 2017 |
Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma.
Topics: Acetamides; Animals; Apoptosis; Azepines; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; CRISPR-Cas Systems; Cyclin D1; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Mice; Mice, SCID; Nuclear Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Skin Neoplasms; Transcription Factors; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Prothioconazole induces cell cycle arrest by up-regulation of EIF4EBP1 in extravillous trophoblast cells.
Topics: Adaptor Proteins, Signal Transducing; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line; Cell Movement; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Female; Fungicides, Industrial; Gene Knockdown Techniques; Humans; Triazoles; Trophoblasts; Up-Regulation | 2022 |